BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37317894)

  • 1. Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma.
    Sabulski A; Abdullah S; Luebbering N; Aunins B; Castillo C; Lake K; Duell A; Strecker L; Langenberg L; Broomhead W; DiMeo S; Odegard EA; Blackard JT; Ziady AG; Seif AE; Dandoy CE; Laskin BL; Jodele S; Davies SM
    Haematologica; 2023 Dec; 108(12):3449-3453. PubMed ID: 37317894
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma.
    Tolbert VP; Dvorak CC; Golden C; Vissa M; El-Haj N; Perwad F; Matthay KK; Vo KT
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2031-2039. PubMed ID: 31199983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy associated with monoclonal gammopathy following autologous hematopoietic stem cell transplantation for neuroblastoma in a young child.
    Henry M; Valentini RP; Savaşan S
    Bone Marrow Transplant; 2017 Dec; 52(12):1662-1664. PubMed ID: 28825693
    [No Abstract]   [Full Text] [Related]  

  • 4. Transplant-associated thrombotic microangiopathy.
    Renaudon-Smith E; De La Fuente J; Bain BJ
    Am J Hematol; 2016 Nov; 91(11):1160. PubMed ID: 27348509
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe, persistent neurotoxicity after transplant-associated thrombotic microangiopathy in a pediatric patient despite treatment with eculizumab.
    Schoettler M; Duncan C; Lehmann L
    Pediatr Transplant; 2019 May; 23(3):e13381. PubMed ID: 30828947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
    Schoettler M; Lehmann L; Li A; Ma C; Duncan C
    Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma.
    Jodele S; Dandoy CE; Myers K; Wallace G; Lane A; Teusink-Cross A; Weiss B; Davies SM
    Bone Marrow Transplant; 2018 Oct; 53(10):1311-1318. PubMed ID: 29674658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease?
    Vaughn JL; Zhao Q; Epperla N; Puto M; Roddy J; Elder P; Blum W; Klisovic R; Jaglowski S; Penza S; William B; Andritsos L; Brammer JE; Hofmeister C; Efebera Y; Benson D; Devine S; Cataland S; Vasu S
    Bone Marrow Transplant; 2019 Jun; 54(6):913-916. PubMed ID: 30413812
    [No Abstract]   [Full Text] [Related]  

  • 9. A Complete Histologic Approach to Gastrointestinal Biopsy From Hematopoietic Stem Cell Transplant Patients With Evidence of Transplant-Associated Gastrointestinal Thrombotic Microangiopathy.
    Warren M; Jodele S; Dandoy C; Myers KC; Wallace G; Nelson A; El-Bietar J
    Arch Pathol Lab Med; 2017 Nov; 141(11):1558-1566. PubMed ID: 28795840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies.
    Abusin GA; Abu-Arja R; Bajwa RPS; Horwitz EM; Auletta JJ; Rangarajan HG
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28333416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults.
    Alhomoud M; Williams A; Magro C; Van Besien K; Vesole DH; Laurence J
    Leuk Lymphoma; 2022 Feb; 63(2):473-477. PubMed ID: 34668824
    [No Abstract]   [Full Text] [Related]  

  • 12. Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.
    Vasu S; Wu H; Satoskar A; Puto M; Roddy J; Blum W; Klisovic R; Andritsos L; Hofmeister C; Benson DM; Efebera Y; Jaglowski S; Penza S; Cohen D; Devine S; Cataland S
    Bone Marrow Transplant; 2016 Sep; 51(9):1241-4. PubMed ID: 27064689
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advances in research on haematopoietic stem cell transplantation-associated thrombotic microangiopathy].
    Chen X; Feng SZ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):560-3. PubMed ID: 22338184
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advances in Diagnosis and Treatment of Transplant-Associated Thrombotic Microangiopathy --Review].
    Geng YK; Wang T; Song ZQ; Yang JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):602-606. PubMed ID: 37096542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
    Khosla J; Yeh AC; Spitzer TR; Dey BR
    Bone Marrow Transplant; 2018 Feb; 53(2):129-137. PubMed ID: 28967899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testicular thrombotic microangiopathy: An unrecognized complication.
    Sabulski A; Szabo S; Myers KC; Davies SM; Jodele S
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29128. PubMed ID: 34019336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of transplantation-associated thrombotic microangiopathy with autopsy-proven fatal myocardial ischemia after allogeneic hematopoietic stem cell transplantation.
    Sasaki K; Honda A; Shinozaki-Ushiku A; Fujioka Y; Maki H; Toyama K; Ushiku T; Kurokawa M
    Ann Hematol; 2021 Jun; 100(6):1621-1622. PubMed ID: 32372148
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmapheresis-refractory thrombotic microangiopathy in a hematopoietic stem cell transplant recipient.
    Vasko R; Groenewold F; Korsten P; Müller GA; Koziolek M
    Ther Apher Dial; 2011 Oct; 15(5):507-9. PubMed ID: 21974708
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.
    Jodele S; Licht C; Goebel J; Dixon BP; Zhang K; Sivakumaran TA; Davies SM; Pluthero FG; Lu L; Laskin BL
    Blood; 2013 Sep; 122(12):2003-7. PubMed ID: 23814021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy.
    Elhadad S; Chadburn A; Magro C; Van Besien K; Roberson EDO; Atkinson JP; Terry H; Greenberg J; Reid W; Chapin J; Copertino D; Geramfard S; Rodriguez LB; Orfali N; Gerghis U; Shore T; Mayer S; Ahamed J; Laurence J
    Bone Marrow Transplant; 2022 Sep; 57(9):1445-1447. PubMed ID: 35661836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.